T38.2X2A Poisoning by antithyroid drugs, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by antithyroid drugs, intentional self-harm, initial encounter

Summary

This condition involves intentional self-harm resulting from exposure to antithyroid drugs during an initial encounter. Antithyroid agents are used to treat hyperthyroidism by inhibiting thyroid hormone production, and intentional ingestion or overdose can lead to adverse effects. The code applies when the exposure is deliberate and represents the first episode of care for the poisoning.

Causes

The cause is intentional ingestion or exposure to antithyroid drugs, such as methimazole or propylthiouracil, with the intent to self-harm. This may occur due to deliberate overdose, misuse, or suicidal behavior. The event is intentional and not accidental, and the code is used for the initial encounter related to this poisoning.

Risk Factors

• Use of antithyroid drug therapy for hyperthyroidism
• History of mental health conditions or suicidal ideation
• Access to antithyroid medications without supervision
• Previous self-harm or overdose attempts
• Social or environmental stressors contributing to intentional harm

Symptoms

Symptoms may include hypothyroidism (e.g., fatigue, weight gain, cold intolerance), gastrointestinal distress (e.g., nausea, vomiting), or other drug-specific adverse effects. Severe poisoning can lead to metabolic disturbances, organ dysfunction, or life-threatening complications. The severity depends on the dose and individual sensitivity.

Diagnosis

Diagnosis is based on a detailed history of the exposure, clinical evaluation of symptoms, and confirmation of antithyroid drug ingestion. Laboratory tests may include thyroid function studies, drug levels, and metabolic panels to assess organ function. A psychiatric evaluation is often necessary to address the underlying intent.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and preventing further harm. This may include decontamination (if appropriate), supportive care (e.g., fluid resuscitation, electrolyte correction), and specific antidotes or therapies to counteract drug effects. Psychiatric intervention and safety planning are critical components of care.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying health status. Early intervention improves outcomes, but severe cases may result in long-term complications or mortality. Follow-up includes monitoring thyroid function, addressing psychiatric needs, and ensuring medication safety to prevent recurrence.

Complications

Complications can include severe hypothyroidism, organ damage (e.g., liver or kidney failure), metabolic acidosis, or cardiovascular instability. Long-term effects may involve persistent thyroid dysfunction or psychological sequelae. In severe cases, death may occur.

Lifestyle & Prevention

Prevention involves secure storage of medications, education on safe use, and addressing underlying mental health concerns. Patients with a history of self-harm should have access to support systems and crisis intervention resources. Regular follow-up with healthcare providers can help manage hyperthyroidism and reduce the risk of intentional overdose.

When to Seek Professional Help

Seek immediate medical attention if intentional ingestion of antithyroid drugs is suspected, or if symptoms such as severe fatigue, confusion, vomiting, or difficulty breathing occur. Prompt care is essential to minimize harm and address the underlying intent.

Tips for Medical Coders

This code is used for the initial encounter of intentional self-harm due to antithyroid drug poisoning. Document the intent (intentional self-harm) and the episode of care (initial encounter) clearly. Ensure the diagnosis aligns with clinical findings and history. Do not use this code for accidental or undetermined intent poisonings.